Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs LPLA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Captures Overall Composite Edge (44.5 HOLD vs 54.0 HOLD), While LPLA Leads 3–2 on Growth & Valuation Pillars

NMR Overall Winner 6-Pillar Tally: NMR 2 – 3 LPLA (1 Tie) Matrix Metrics: NMR 6 – 3 LPLA

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) captures the overall head-to-head institutional edge over LPL Financial Holdings Inc. (LPLA) on higher Unified Composite conviction (44.5/100 HOLD vs. 54.0/100 HOLD) after splitting the core matrix 6–3 (led by Profitability & Quality, R&D & Supply-Chain Moat), while LPLA wins 3–2 across the 6-pillar growth and valuation breakdown. NMR trades at $9.34 (12.7x Forward P/E, 25.1% operating margin) versus LPLA at $283.19 (9.8x Forward P/E, 10.8% operating margin).

  • Composite vs. Pillar Nuance: While LPLA currently prints a higher short-term Unified Composite Score (54.0/100 HOLD vs. NMR 44.5/100 HOLD), NMR captures the overall institutional head-to-head verdict (6–3 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 10.8% operating margin) and revenue trajectory (+17.9% vs. +17.8% YoY).
  • Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile LPLA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs LPLA
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
LPLA NASDAQ
LPL Financial Holdings Inc.
Security & Commodity Brokers, Dealers, Exchanges & Services
$283.19
-2.46% 1D
Market Cap $22.8B
TTM Revenue $20.0B
Forward P/E 9.8x
Beta / 30D Vol 0.58β · 64% Vol
Unified Composite Score
54.0 / 100 HOLD
Tech 60.0 Fund 56.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 38
RSI-14: 38.3 · SMA20: $300.10 · SMA50: $315.19

6-Pillar Scorecard Institutional Category Breakdown (NMR 2 – 3 LPLA)

Columns: Metric · NMR · LPLA
1. Valuation Multiples LPLA
Forward P/E 12.7x 9.8x
Trailing P/E 11.2x 16.8x
PEG Ratio 0.81x 0.37x
EV / Revenue 1.9x 1.1x
2. Growth & Scale LPLA
Revenue Growth (YoY) +17.9% +17.8%
Earnings Growth (YoY) +13.6% +39.4%
TTM Revenue (USD) $14.9B $20.0B
Market Cap $28.3B $22.8B
3. Profitability & Quality NMR
Gross Margin 77.4% 29.6%
Operating Margin 25.1% 10.8%
Net Profit Margin 17.1% 7.0%
Return on Equity (ROE) 11.5% 25.7%
4. Balance Sheet & Cash Flow LPLA
Cash Generation (TTM) N/A $2.11B EBITDA
Cash Flow Margin N/A 10.6% EBITDA Mgn
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $74.22 Book/Sh · 25.7% ROE
Dividend Yield 3.34% 0.41%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 30.7% (<1st %ile) 29.5% (12th %ile)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat NMR
OpEx & R&D Intensity 52.3% of Rev ($7.77B) 18.8% of Rev ($3.76B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (6) vs LPLA (3)
Institutional Metric NMR LPLA Criterion Row Edge
Market Capitalization
Scale
$28.3B $22.8B Larger Scale NMR
Trailing P/E Ratio
Valuation
11.2x 16.8x Lower Multiple NMR
Forward P/E Ratio
Valuation
12.7x 9.8x Lower Multiple LPLA
Revenue Growth (YoY)
Growth
+17.9% +17.8% Higher Growth Tie
Operating Margin (TTM)
Profitability
25.1% 10.8% Higher Margin NMR
Net Profit Margin
Profitability
17.1% 7.0% Higher Margin NMR
Return on Equity (ROE)
Capital Efficiency
11.5% 25.7% Higher ROE LPLA
52-Week Range Position
Momentum
60% ($7–$11) 16% ($260–$400) Stronger Trend NMR
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol 0.58β · 64% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 54.0 / 100 (HOLD) Higher Composite LPLA
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $20.0B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 29.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev 0.37x PEG · 1.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) $2.11B EBITDA ($74.22 Book/Sh · 25.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +12.79 pp
NMR: +2.36% · LPLA: -10.43%
3M Horizon NMR +19.33 pp
NMR: -1.84% · LPLA: -21.17%
6M Horizon NMR +18.14 pp
NMR: +16.69% · LPLA: -1.45%
1Y Horizon NMR +49.9 pp
NMR: +26.32% · LPLA: -23.58%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs LPLA. Trailing 12-month operating profitability (NMR 25.1% vs LPLA 10.8%) and valuation multiples (NMR 12.7x vs LPLA 9.8x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
LPLA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$20.0B
Gross Margin29.6%
Op. Margin10.8%
ROE / Fwd P/E25.7% · 9.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LPLA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 29.5%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LPLA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
LPLA Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $22.8B market capitalization and 10.8% operating margin.
OpEx & R&D Reinvestment 18.8% of Rev ($3.76B)
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs LPLA Key Questions & Quantitative Answers

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) captures the overall head-to-head institutional edge over LPL Financial Holdings Inc. (LPLA) on higher Unified Composite conviction (44.5/100 HOLD vs. 54.0/100 HOLD) after splitting the core matrix 6–3 (led by Profitability & Quality, R&D & Supply-Chain Moat), while LPLA wins 3–2 across the 6-pillar growth and valuation breakdown. NMR trades at $9.34 (12.7x Forward P/E, 25.1% operating margin) versus LPLA at $283.19 (9.8x Forward P/E, 10.8% operating margin). Composite vs. Pillar Nuance: While LPLA currently prints a higher short-term Unified Composite Score (54.0/100 HOLD vs. NMR 44.5/100 HOLD), NMR captures the overall institutional head-to-head verdict (6–3 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 10.8% operating margin) and revenue trajectory (+17.9% vs. +17.8% YoY). Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile LPLA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

LPLA leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with LPLA at +17.8% YoY revenue growth and +39.4% YoY earnings growth on $20.0B TTM revenue (29.6% gross margin, 10.8% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $20.0B for LPLA. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 18.8% of Rev ($3.76B) (0 disclosures) for LPLA.

LPLA screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas LPLA trades at 9.8x Forward P/E, 16.8x Trailing P/E, 0.37x PEG, and 1.1x EV/Revenue (10.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus LPLA (25.7% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, LPLA carries 29.5% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.58β · 64% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.